SB-505124: Difference between revisions
Jump to navigation
Jump to search
imported>Xenbase |
imported>Xenbase |
||
| Line 2: | Line 2: | ||
SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7 . | SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7 . | ||
==Alternative names== | ==Alternative names== | ||
SB505124 | *SB505124 | ||
SB 505124 | *SB 505124 | ||
2-[4-(1,3-Benzodioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl]-6-methylpyridine | *2-[4-(1,3-Benzodioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl]-6-methylpyridine | ||
==Usage Notes== | ==Usage Notes== | ||
==References== | ==References== | ||
Latest revision as of 11:05, 15 January 2021
Description
SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7 .
Alternative names
- SB505124
- SB 505124
- 2-[4-(1,3-Benzodioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl]-6-methylpyridine
Usage Notes
References
> 11 Xenbase articles contain a reference to SB-505124 according to textpresso